ValiRx's Cytolytix secures European patent for nanoparticle delivery tickstock newsroom · 08:43, 27 May 2026
Itaconix launches deeperclean.com to market its formulated detergents tickstock newsroom · 08:04, 27 May 2026
AstraZeneca says FDA extends decision date for camizestrant, allowing extra data review tickstock newsroom · 07:30, 27 May 2026
Health & Bio Today: Genedrive chairman exits as Nugent joins board, Novo Nordisk, Crism, Diaceutics, CVS Group, AstraZeneca, tickstock newsroom · 17:20, 26 May 2026
BSF Enterprise shares roars as investors look to 'T‑Rex Leather' auction tickstock newsroom · 13:45, 26 May 2026 · Updated 17:04, 26 May
Ondine Biomedical reports ICU feasibility study with signals of reduced pneumonia tickstock newsroom · 15:24, 26 May 2026
CVS Group shares rise on bank refinancing and £50m buyback tickstock newsroom · 07:27, 26 May 2026 · Updated 14:54, 26 May
Tern shares rocketed after loan note deal tickstock newsroom · 10:05, 26 May 2026 · Updated 14:49, 26 May
Novo Nordisk study finds two in five high‑risk cardiovascular patients have persistent inflammation tickstock newsroom · 13:47, 26 May 2026
Serco secures £270m contract from Norfolk and Norwich University Hospital tickstock newsroom · 13:46, 26 May 2026
genedrive appoints major shareholder David Nugent as director as chairman signals exit tickstock newsroom · 13:07, 26 May 2026
CRISM Therapeutics launches retail offer to raise up to £100,000 tickstock newsroom · 10:43, 26 May 2026
The Premarket Brief: Sound Energy sells Tendrara stake for $57m, CVS Group, Arrow Exploration, AstraZeneca, Atalaya Mining tickstock newsroom · 08:42, 26 May 2026
ProBiotix Health signs exclusive Spain and Portugal supply deal with Bioksan tickstock newsroom · 07:42, 26 May 2026
CRISM Therapeutics raises £2.5m to fund Phase 2 trial and grant pursuit tickstock newsroom · 07:40, 26 May 2026
AstraZeneca wins CHMP backing for Enhertu tumour‑agnostic approval tickstock newsroom · 07:30, 26 May 2026
Health & Bio Today: Creo Medical raises £5.5m and sells 49% stake in unit, Rua Life Sciences tickstock newsroom · 17:16, 23 May 2026
RUA Life Sciences sees higher first half revenue, and earnings breakeven tickstock newsroom · 13:16, 22 May 2026
Health & Bio Today: EMV Capital spotlights XF-73 ahead of Phase 3, IXICO, Oxford Nanopore, AstraZeneca tickstock newsroom · 23:13, 21 May 2026
Broker calls AstraZeneca pipeline news “frenetic”, repeats Sell rating tickstock newsroom · 15:16, 21 May 2026
EMV Capital commercial update spotlights XF-73 as it moves toward Phase 3 tickstock newsroom · 14:59, 21 May 2026
IXICO wins £1.3m Alzheimer's and Huntington's clinical analytics contracts tickstock newsroom · 13:58, 21 May 2026
4basebio wins opDNA supply deal for Phase II immunotherapy trial tickstock newsroom · 07:16, 21 May 2026
Big Pharma's AI arms race intensifies as Bristol Myers Squibb hands Anthropic the keys to the enterprise tickstock newsroom · 19:07, 20 May 2026
Mears Group wins £240m Thurrock repairs and investment contract tickstock newsroom · 11:48, 19 May 2026
Health & Bio Today: AstraZeneca wins dual FDA approvals, Advanced Medical Solutions, CelLBxHealth, GSK tickstock newsroom · 07:31, 19 May 2026
Stockbroker sticks with a Buy on Advanced Medical Solutions after suitor slips away tickstock newsroom · 11:30, 18 May 2026
CelLBxHealth to deploy Parsortix with AdventHealth for two US clinical studies tickstock newsroom · 09:34, 18 May 2026
ValiRx raises up to £1.155m to fund McGill in‑licence, Cytolytix preclinical work and animal‑health expansion tickstock newsroom · 09:00, 18 May 2026
AstraZeneca secures US approval for blood pressure drug Baxfendy tickstock newsroom · 08:49, 18 May 2026
Spire Healthcare receives 250p per-share takeover proposal from Toscafund tickstock newsroom · 09:24, 15 May 2026
AstraZeneca says Imfinzi plus enfortumab vedotin improves survival in muscle‑invasive bladder cancer tickstock newsroom · 08:51, 15 May 2026
Health & Bio Today: Adaptix wins CE mark for Ortho350, Physiomics, IXICO, Novo Nordisk tickstock newsroom · 19:02, 12 May 2026
IP Group's Enterprise Therapeutics hits primary endpoint in Phase 2 cystic fibrosis trial tickstock newsroom · 18:55, 12 May 2026
Avingtrans unit Adaptix wins CE mark for Ortho350, clears path to UK and EU sales tickstock newsroom · 09:35, 12 May 2026
RUA Life Sciences spins out RUA Structural Heart and secures funding tickstock newsroom · 09:32, 12 May 2026
The Premarket Brief: Marston's reaffirms FY2026 guidance on margin gains, Angling Direct, Greggs, Wickes, Novo Nordisk, Wizz Air tickstock newsroom · 08:25, 12 May 2026
Market reports Daily reports The Premarket Brief London LIVE Small Caps Today Sector reports Mining Today Oil & Gas Today Health & Bio Today Tech Today
Energy & Resources Topics Oil & Gas Mining & Metals Renewables Nuclear Top Stocks AAL Anglo American ANTO Antofagasta FRES Fresnillo EDV Endeavour Mining GGP Greatland Gold See all companies
Financials Topics Banks Insurance Asset Management Fintech & Payments REITs & Property Top Stocks BARC Barclays HSBA HSBC LLOY Lloyds NWG NatWest AV. Aviva PRU Prudential See all companies
Technology Topics Software & SaaS Semiconductors AI & Machine Learning Cybersecurity Top Stocks SGE Sage Group RPI Raspberry Pi KNOS Kainos SCT Softcat See all companies
Healthcare Topics Pharma Biotech Medtech Healthcare Services Top Stocks AZN AstraZeneca GSK GSK SN. Smith & Nephew HIK Hikma See all companies
Industrials Topics Aerospace & Defence Construction Engineering Transport & Logistics Top Stocks BA. BAE Systems RR. Rolls-Royce BAB Babcock QQ. QinetiQ CHG Chemring See all companies
Consumer Topics Retail Food & Beverage Travel & Leisure Media & Entertainment Top Stocks DGE Diageo ULVR Unilever TSCO Tesco NXT Next See all companies
